HIVACAR aims to provide a new therapeutic alternative

HIVACAR aims to provide a new therapeutic alternative

HIVACAR aims to provide a new therapeutic alternative to “cART for life” (combined antiretroviral therapy) and will address the individual and public health limitations associated with this standard of care:

  • Cost of the medication.
  • Mandatory high adherence to medication for life.
  • Side effects.
  • Risk of resistances developement.

An innovative strategy based on the patient’s immune system, safe, affordable and scalable to achieve the functional cure of HIV-1 infection will be tested in a Phase I / IIa clinical trial. In addition, the ethical, economic and psychosocial challenges associated with a functional HIV cure will be investigated to provide a complementary alternative to the current treatment standard.

News

A community-led psychosocial survey about HIV remission aims to assess the knowledge and expectations among people living with HIV

Are you a person living with #HIV based in Belgium, Denmark, France or Spain? The European AIDS Treatment Group (EATG), HIV community partner within the #HIVACAR initiative, invites you to fill in ๐™– ๐™จ๐™ช๐™ง๐™ซ๐™š๐™ฎ to help better understand ๐™ฎ๐™ค๐™ช๐™ง ๐™ ๐™ฃ๐™ค๐™ฌ๐™ก๐™š๐™™๐™œ๐™š ๐™–๐™—๐™ค๐™ช๐™ฉ ๐™ƒ๐™„๐™‘ ๐™ง๐™š๐™ข๐™ž๐™จ๐™จ๐™ž๐™ค๐™ฃ...